{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T23:23:47Z","timestamp":1788650627533,"version":"build-2803163510"},"reference-count":113,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.pnpbp.2021.110343","type":"journal-article","created":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T22:38:45Z","timestamp":1620167925000},"page":"110343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"special_numbering":"C","title":["Translational evidence for the Inflammatory Response System (IRS)\/Compensatory Immune Response System (CIRS) and neuroprogression theory of major depression"],"prefix":"10.1016","volume":"111","author":[{"given":"Monojit","family":"Debnath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Berk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Maes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2021.110343_bb0005","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s11481-017-9763-4","article-title":"Altered B cell homeostasis in patients with major depressive disorder and normalization of CD5 surface expression on regulatory B cells in treatment responders","volume":"13","author":"Ahmetspahic","year":"2018","journal-title":"J. NeuroImmune Pharmacol."},{"key":"10.1016\/j.pnpbp.2021.110343_bb0010","doi-asserted-by":"crossref","first-page":"812","DOI":"10.3389\/fpsyt.2019.00812","article-title":"Abnormal distribution and function of circulating monocytes and enhanced bacterial translocation in major depressive disorder","volume":"10","author":"Alvarez-Mon","year":"2019","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110343_bb0015","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.2174\/13816128113196660738","article-title":"Oxidative\/nitrosative stress and immuno-inflammatory pathways in depression: treatment implications","volume":"20","author":"Anderson","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.pnpbp.2021.110343_bb0020","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/S1734-1140(13)71526-3","article-title":"Increased IL-6 trans-signaling in depression: focus on the tryptophan catabolite pathway, melatonin and neuroprogression","volume":"65","author":"Anderson","year":"2013","journal-title":"Pharmacol. Rep."},{"issue":"Suppl. 2","key":"10.1016\/j.pnpbp.2021.110343_bb0025","first-page":"57","article-title":"Suicide risk in patients with major depressive disorder","volume":"60","author":"Angst","year":"1999","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110343_bb0030","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1093\/brain\/awg118","article-title":"B lymphocytes in the normal brain: contrasts with HIV-associated lymphoid infiltrates and lymphomas","volume":"126","author":"Anthony","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.pnpbp.2021.110343_bb0035","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.imbio.2014.09.022","article-title":"The activation status of human macrophages presenting antigen determines the efficiency of Th17 responses","volume":"220","author":"Arnold","year":"2015","journal-title":"Immunobiology"},{"key":"10.1016\/j.pnpbp.2021.110343_bb0040","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/imm.12443","article-title":"Immune mechanisms linked to depression via oxidative stress and neuroprogression","volume":"144","author":"Bakunina","year":"2015","journal-title":"Immunology"},{"key":"10.1016\/j.pnpbp.2021.110343_bb0045","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1742-2094-3-7","article-title":"Interferon-gamma increases neuronal death in response to amyloid-beta1-42","volume":"3","author":"Bate","year":"2006","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.pnpbp.2021.110343_bb0050","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1001\/jamapsychiatry.2013.1111","article-title":"Autoimmune diseases and severe infections as risk factors for mood disorders: a nationwide study","volume":"70","author":"Benros","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110343_bb0055","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0022-3999(97)00139-6","article-title":"Acute phase proteins in major depression","volume":"43","author":"Berk","year":"1997","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/j.pnpbp.2021.110343_bb0060","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/1741-7015-11-200","article-title":"So depression is an inflammatory disease, but where does the inflammation come from?","volume":"11","author":"Berk","year":"2013","journal-title":"BMC Med."},{"key":"10.1016\/j.pnpbp.2021.110343_bb0065","doi-asserted-by":"crossref","DOI":"10.1038\/s41380-021-01020-5","article-title":"Effects of aspirin on the long-term management of depression in older people: a double-blind randomised placebo-controlled trial","author":"Berk","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110343_bb0070","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/070674370705200108","article-title":"Definition, assessment, and staging of treatment-resistant refractory major depression: a review of current concepts and methods","volume":"52","author":"Berlim","year":"2007","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.pnpbp.2021.110343_bb0075","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.biopsych.2012.09.021","article-title":"Inflammatory T helper 17 cells promote depression-like behavior in mice","volume":"73","author":"Beurel","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110343_bb0080","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/s41380-019-0408-2","article-title":"Systemic inflammation is associated with depressive symptoms differentially by sex and race: a longitudinal study of urban adults","volume":"25","author":"Beydoun","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110343_bb0085","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1073\/pnas.0915139107","article-title":"Inhibitory role for GABA in autoimmune inflammation","volume":"107","author":"Bhat","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pnpbp.2021.110343_bb0090","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1093\/ijnp\/pyaa055","article-title":"Pro- and anti-inflammatory properties of interleukin (IL6) in vitro: relevance for major depression and for human hippocampal neurogenesis","volume":"23","author":"Borsini","year":"2020","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2021.110343_bb0095","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/s41398-020-00992-2","article-title":"Single-cell mass cytometry of microglia in major depressive disorder reveals a non-inflammatory phenotype with increased homeostatic marker expression","volume":"10","author":"Bottcher","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110343_bb0100","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1176\/ajp.157.1.115","article-title":"Hippocampal volume reduction in major depression","volume":"157","author":"Bremner","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110343_bb0105","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3389\/fncel.2015.00476","article-title":"Neuroinflammation and depression: microglia activation, extracellular microvesicles and microRNA dysregulation","volume":"9","author":"Brites","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.pnpbp.2021.110343_bb0110","doi-asserted-by":"crossref","first-page":"705379","DOI":"10.1155\/2009\/705379","article-title":"Inhibitory effects of ketamine on lipopolysaccharide-induced microglial activation","volume":"2009","author":"Chang","year":"2009","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.pnpbp.2021.110343_bb0115","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.psychres.2018.08.078","article-title":"Rapid inflammation modulation and antidepressant efficacy of a low-dose ketamine infusion in treatment-resistant depression: a randomized, double-blind control study","volume":"269","author":"Chen","year":"2018","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pnpbp.2021.110343_bb0120","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-1-59745-396-7_3","article-title":"Macrophage activation: classical versus alternative","volume":"531","author":"Classen","year":"2009","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.pnpbp.2021.110343_bb0125","first-page":"137","article-title":"Elevated IL-17 and TGF-beta serum levels: a positive correlation between T-helper 17 cell-related pro-inflammatory responses with major depressive disorder","volume":"7","author":"Davami","year":"2016","journal-title":"Basic Clin. Neurosci."},{"key":"10.1016\/j.pnpbp.2021.110343_bb0130","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000014526","article-title":"Cytokine-neurotransmitter interactions in the brain","volume":"7","author":"De Simoni","year":"1998","journal-title":"Biol. Signals"},{"key":"10.1016\/j.pnpbp.2021.110343_bb0135","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1001\/jama.291.21.2581","article-title":"Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys","volume":"291","author":"Demyttenaere","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.pnpbp.2021.110343_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/ph11030064","article-title":"Insights into macrophage heterogeneity and cytokine-induced neuroinflammation in major depressive disorder","volume":"11","author":"Dey","year":"2018","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.pnpbp.2021.110343_bb0145","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110343_bb0150","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bbi.2019.06.015","article-title":"Markers of central inflammation in major depressive disorder: a systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue","volume":"81","author":"Enache","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.pnpbp.2021.110343_bb0155","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.yfrne.2012.09.003","article-title":"Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaise","volume":"33","author":"Felger","year":"2012","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.pnpbp.2021.110343_bb0160","doi-asserted-by":"crossref","first-page":"112811","DOI":"10.1016\/j.bbr.2020.112811","article-title":"Circulating T helper 17 and IFN-gamma positive Th17 cells in Major Depressive Disorder","volume":"394","author":"Ghosh","year":"2020","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pnpbp.2021.110343_bb0165","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/ni.3423","article-title":"Origin, fate and dynamics of macrophages at central nervous system interfaces","volume":"17","author":"Goldmann","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.pnpbp.2021.110343_bb0170","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/sj.mp.4002055","article-title":"Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression","volume":"13","author":"Goshen","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110343_bb0175","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.bbi.2015.12.003","article-title":"Deficiencies of the T and natural killer cell system in major depressive disorder: T regulatory cell defects are associated with inflammatory monocyte activation","volume":"54","author":"Grosse","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.pnpbp.2021.110343_bb0180","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.pnpbp.2015.11.012","article-title":"Innate and adaptive immunity in the development of depression: an update on current knowledge and technological advances","volume":"66","author":"Haapakoski","year":"2016","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110343_bb0185","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1038\/npp.2011.132","article-title":"The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis","volume":"36","author":"Hannestad","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2021.110343_bb0190","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000343100","article-title":"Imbalance between Th17 and Treg cells may play an important role in the development of chronic unpredictable mild stress-induced depression in mice","volume":"20","author":"Hong","year":"2013","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.pnpbp.2021.110343_bb0195","doi-asserted-by":"crossref","first-page":"10054","DOI":"10.1038\/s41598-018-28300-5","article-title":"Relationship between interleukin (IL)-6 and brain morphology in drug-naive, first-episode major depressive disorder using surface-based morphometry","volume":"8","author":"Kakeda","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pnpbp.2021.110343_bb0200","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1001\/archgenpsychiatry.2011.60","article-title":"Structural neuroimaging studies in major depressive disorder. Meta-analysis and comparison with bipolar disorder","volume":"68","author":"Kempton","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110343_bb0205","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1017\/S1461145709009924","article-title":"A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder","volume":"12","author":"Khairova","year":"2009","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2021.110343_bb0210","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.pnpbp.2007.03.004","article-title":"Cytokine imbalance in the pathophysiology of major depressive disorder","volume":"31","author":"Kim","year":"2007","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110343_bb0215","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41398-020-01164-y","article-title":"The IL-6 antagonist tocilizumab is associated with worse depression and related symptoms in the medically ill","volume":"11","author":"Knight","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110343_bb0220","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1001\/jamapsychiatry.2014.1611","article-title":"Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials","volume":"71","author":"Kohler","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110343_bb0225","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/acps.13016","article-title":"Efficacy of anti-inflammatory treatment on major depressive disorder or depressive symptoms: meta-analysis of clinical trials","volume":"139","author":"Kohler-Forsberg","year":"2019","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.pnpbp.2021.110343_bb0230","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.intimp.2003.11.006","article-title":"Stimulatory effect of antidepressants on the production of IL-6","volume":"4","author":"Kubera","year":"2004","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.pnpbp.2021.110343_bb0235","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.psyneuen.2009.06.007","article-title":"Serum chemokine levels in major depressive disorder","volume":"35","author":"Lehto","year":"2010","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pnpbp.2021.110343_bb0240","first-page":"R652","article-title":"Central administration of rat IL-6 induces HPA activation and fever but not sickness behavior in rats","volume":"276","author":"Lenczowski","year":"1999","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.pnpbp.2021.110343_bb0245","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2174\/157339510791823835","article-title":"The concept of depression as a dysfunction of the immune system","volume":"6","author":"Leonard","year":"2010","journal-title":"Curr. Immunol. Rev."},{"key":"10.1016\/j.pnpbp.2021.110343_bb0250","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jad.2009.10.018","article-title":"Altered expression of CD4(+)CD25(+) regulatory T cells and its 5-HT(1a) receptor in patients with major depression disorder","volume":"124","author":"Li","year":"2010","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2021.110343_bb0255","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41380-019-0474-5","article-title":"Peripheral cytokine levels and response to antidepressant treatment in depression: a systematic review and meta-analysis","volume":"25","author":"Liu","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110343_bb0260","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1515\/REVNEURO.1993.4.4.407","article-title":"A review on the acute phase response in major depression","volume":"4","author":"Maes","year":"1993","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.pnpbp.2021.110343_bb0265","doi-asserted-by":"crossref","first-page":"8885","DOI":"10.1007\/s12035-018-1016-x","article-title":"The Compensatory Immune-Regulatory Reflex System (CIRS) in depression and bipolar disorder","volume":"55","author":"Maes","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.pnpbp.2021.110343_bb0270","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000119472","article-title":"Immune disturbances during major depression: upregulated expression of interleukin-2 receptors","volume":"24","author":"Maes","year":"1990","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.pnpbp.2021.110343_bb0275","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1017\/S0033291700032712","article-title":"Evidence for a systemic immune activation during depression: results of leukocyte enumeration by flow cytometry in conjunction with monoclonal antibody staining","volume":"22","author":"Maes","year":"1992","journal-title":"Psychol. Med."},{"key":"10.1016\/j.pnpbp.2021.110343_bb0280","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0278-5846(93)90045-T","article-title":"Significantly increased expression of T-cell activation markers (interleukin-2 and HLA-DR) in depression: further evidence for an inflammatory process during that illness","volume":"17","author":"Maes","year":"1993","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110343_bb0285","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0165-0327(95)00028-L","article-title":"Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression","volume":"34","author":"Maes","year":"1995","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2021.110343_bb0290","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0306-4530(94)00066-J","article-title":"The monocyte-T-lymphocyte hypothesis of major depression","volume":"20","author":"Maes","year":"1995","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pnpbp.2021.110343_bb0295","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1006\/cyto.1997.0238","article-title":"Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression","volume":"9","author":"Maes","year":"1997","journal-title":"Cytokine"},{"key":"10.1016\/j.pnpbp.2021.110343_bb0300","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0893-133X(98)00088-8","article-title":"Negative immunoregulatory effects of antidepressants: inhibition of interferon-gamma and stimulation of interleukin-10 secretion","volume":"20","author":"Maes","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2021.110343_bb0305","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.pnpbp.2011.09.006","article-title":"Activation of cell-mediated immunity in depression: association with inflammation, melancholia, clinical staging and the fatigue and somatic symptom cluster of depression","volume":"36","author":"Maes","year":"2012","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110343_bb0310","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1517\/14728222.2014.888417","article-title":"Targeting classical IL-6 signalling or IL-6 trans-signalling in depression?","volume":"18","author":"Maes","year":"2014","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.pnpbp.2021.110343_bb0315","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.it.2004.09.015","article-title":"The chemokine system in diverse forms of macrophage activation and polarization","volume":"25","author":"Mantovani","year":"2004","journal-title":"Trends Immunol."},{"key":"10.1016\/j.pnpbp.2021.110343_bb0320","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jpsychires.2008.02.004","article-title":"IL-10 modulates depressive-like behavior","volume":"43","author":"Mesquita","year":"2008","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.pnpbp.2021.110343_bb0325","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000470804","article-title":"Neuroprogression and immune activation in major depressive disorder","volume":"31","author":"Meyer","year":"2017","journal-title":"Mod. Trends Pharmacopsychiatry"},{"key":"10.1016\/j.pnpbp.2021.110343_bb0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbi.2009.09.009","article-title":"Depression and immunity: a role for T cells?","volume":"24","author":"Miller","year":"2010","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.pnpbp.2021.110343_bb0335","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1159\/000364945","article-title":"M1 and M2 macrophages: the chicken and the egg of immunity","volume":"6","author":"Mills","year":"2014","journal-title":"J. Innate Immun."},{"key":"10.1016\/j.pnpbp.2021.110343_bb0340","doi-asserted-by":"crossref","first-page":"6166","DOI":"10.4049\/jimmunol.164.12.6166","article-title":"M-1\/M-2 macrophages and the Th1\/Th2 paradigm","volume":"164","author":"Mills","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.pnpbp.2021.110343_bb0345","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","article-title":"Interleukin-10 and the interleukin-10 receptor","volume":"19","author":"Moore","year":"2001","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.pnpbp.2021.110343_bb0350","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/mp.2012.33","article-title":"The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications","volume":"18","author":"Moylan","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110343_bb0355","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/sj.mp.4002006","article-title":"The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression","volume":"12","author":"Muller","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110343_bb0360","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1146\/annurev-physiol-022516-034339","article-title":"Macrophage polarization","volume":"79","author":"Murray","year":"2017","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.pnpbp.2021.110343_bb0365","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","article-title":"Macrophage activation and polarization: nomenclature and experimental guidelines","volume":"41","author":"Murray","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.pnpbp.2021.110343_bb0370","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ebiom.2019.10.063","article-title":"Pro-inflammatory monocyte profile in patients with major depressive disorder and suicide behaviour and how ketamine induces anti-inflammatory M2 macrophages by NMDAR and mTOR","volume":"50","author":"Nowak","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.pnpbp.2021.110343_bb0375","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.bbi.2020.02.010","article-title":"Inflammatory markers in depression: a meta-analysis of mean differences and variability in 5,166 patients and 5,083 controls","volume":"87","author":"Osimo","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.pnpbp.2021.110343_bb0380","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000470809","article-title":"Inflammatory and innate immune markers of neuroprogression in depressed and teenage suicide brain","volume":"31","author":"Pandey","year":"2017","journal-title":"Mod. Trends Pharmacopsychiatry"},{"key":"10.1016\/j.pnpbp.2021.110343_bb0385","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jpsychires.2011.08.006","article-title":"Proinflammatory cytokines in the prefrontal cortex of teenage suicide victims","volume":"46","author":"Pandey","year":"2012","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.pnpbp.2021.110343_bb0390","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bbi.2018.09.024","article-title":"Innate immunity in the postmortem brain of depressed and suicide subjects: role of Toll-like receptors","volume":"75","author":"Pandey","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.pnpbp.2021.110343_bb0395","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3389\/fimmu.2018.00291","article-title":"T cell phenotype and T cell receptor repertoire in patients with major depressive disorder","volume":"9","author":"Patas","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.pnpbp.2021.110343_bb0400","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1152\/physrev.90100.2007","article-title":"Muscle as an endocrine organ: focus on muscle-derived interleukin-6","volume":"88","author":"Pedersen","year":"2008","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.pnpbp.2021.110343_bb0405","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cyto.2014.09.011","article-title":"T cell subsets and their signature cytokines in autoimmune and inflammatory diseases","volume":"74","author":"Raphael","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.pnpbp.2021.110343_bb0410","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0165-1781(01)00338-9","article-title":"Immunological differences between patients with major depression and somatization syndrome","volume":"105","author":"Rief","year":"2001","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pnpbp.2021.110343_bb0415","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.3389\/fimmu.2018.01625","article-title":"Expanded regulatory T cells induce alternatively activated monocytes with a reduced capacity to expand T Helper-17 cells","volume":"9","author":"Romano","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.pnpbp.2021.110343_bb0420","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.bbi.2020.02.005","article-title":"Depression and suicidality: a link to premature T helper cell aging and increased Th17 cells","volume":"87","author":"Schiweck","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.pnpbp.2021.110343_bb0425","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/mp.2015.69","article-title":"Subcortical brain alterations in major depressive disorder: findings from the ENIGMA major depressive disorder working group","volume":"21","author":"Schmaal","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110343_bb0430","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/icb.2016.34","article-title":"Human macrophages induce CD4(+)Foxp3(+) regulatory T cells via binding and re-release of TGF-beta","volume":"94","author":"Schmidt","year":"2016","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.pnpbp.2021.110343_bb0435","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/apha.12430","article-title":"The role of serotonin and its receptors in activation of immune responses and inflammation","volume":"213","author":"Shajib","year":"2015","journal-title":"Acta Physiol (Oxford)"},{"key":"10.1016\/j.pnpbp.2021.110343_bb0440","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/0306-9877(91)90272-Z","article-title":"The macrophage theory of depression","volume":"35","author":"Smith","year":"1991","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.pnpbp.2021.110343_bb0445","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.pnpbp.2010.06.020","article-title":"Cytokines mediated inflammation and decreased neurogenesis in animal models of depression","volume":"35","author":"Song","year":"2011","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110343_bb0450","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s12640-017-9835-5","article-title":"Lipid peroxidation and immune biomarkers are associated with major depression and its phenotypes, including treatment-resistant depression and melancholia","volume":"33","author":"Sowa-Kucma","year":"2018","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.pnpbp.2021.110343_bb0455","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/PCC.0b013e3181b01042","article-title":"Hypothermia increases interleukin-6 and interleukin-10 in juvenile endotoxemic mice","volume":"11","author":"Stewart","year":"2010","journal-title":"Pediatr. Crit. Care Med."},{"key":"10.1016\/j.pnpbp.2021.110343_bb0460","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41398-018-0174-y","article-title":"Relationship between white matter integrity and serum inflammatory cytokine levels in drug-naive patients with major depressive disorder: diffusion tensor imaging study using tract-based spatial statistics","volume":"8","author":"Sugimoto","year":"2018","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110343_bb0465","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.bbi.2017.06.011","article-title":"Altered populations of natural killer cells, cytotoxic T lymphocytes, and regulatory T cells in major depressive disorder: association with sleep disturbance","volume":"66","author":"Suzuki","year":"2017","journal-title":"Brain Behav. Immun."},{"issue":"914\u2013924","key":"10.1016\/j.pnpbp.2021.110343_bb0470","article-title":"Defective inflammatory pathways in never-treated depressed patients are associated with poor treatment response","volume":"99","author":"Syed","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.pnpbp.2021.110343_bb0475","doi-asserted-by":"crossref","first-page":"19446","DOI":"10.1073\/pnas.0706832104","article-title":"CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes\/macrophages","volume":"104","author":"Tiemessen","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pnpbp.2021.110343_bb0480","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.bbi.2014.05.007","article-title":"Evidence for increased microglial priming and macrophage recruitment in the dorsal anterior cingulate white matter of depressed suicides","volume":"42","author":"Torres-Platas","year":"2014","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.pnpbp.2021.110343_bb0485","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1176\/appi.ajp.161.11.1957","article-title":"Hippocampal volume and depression: a meta-analysis of MRI studies","volume":"161","author":"Videbech","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110343_bb0490","doi-asserted-by":"crossref","first-page":"30212","DOI":"10.1074\/jbc.M602156200","article-title":"Interleukin-1 beta released by gp120 drives neural death through tyrosine phosphorylation and trafficking of NMDA receptors","volume":"281","author":"Viviani","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pnpbp.2021.110343_bb0495","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0193-953X(05)70364-6","article-title":"Neurodevelopmental and neuroprogressive processes in schizophrenia. Antithetical or complementary, over a lifetime trajectory of disease?","volume":"21","author":"Waddington","year":"1998","journal-title":"Psychiatr Clin North Am"},{"key":"10.1016\/j.pnpbp.2021.110343_bb0500","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12974-018-1054-3","article-title":"Microglial activation mediates chronic mild stress-induced depressive- and anxiety-like behavior in adult rats","volume":"15","author":"Wang","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.pnpbp.2021.110343_bb0505","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2147\/NDT.S151238","article-title":"Plasma complement component 4 increases in patients with major depressive disorder","volume":"14","author":"Wei","year":"2018","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.pnpbp.2021.110343_bb0510","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.pnpbp.2017.04.026","article-title":"Effect of antidepressant treatment on peripheral inflammation markers \u2013 a meta-analysis","volume":"80","author":"Wiedlocha","year":"2018","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110343_bb0515","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1038\/s41380-019-0471-8","article-title":"Effects of immunomodulatory drugs on depressive symptoms: a mega-analysis of randomized, placebo-controlled clinical trials in inflammatory disorders","volume":"25","author":"Wittenberg","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110343_bb0520","first-page":"R861","article-title":"Interleukin-6 contributes to early fasting-induced free fatty acid mobilization in mice","volume":"306","author":"Wueest","year":"2014","journal-title":"Am. J. Phys. Regul. Integr. Comp. Phys."},{"key":"10.1016\/j.pnpbp.2021.110343_bb0525","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1172\/JCI1368","article-title":"IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses","volume":"101","author":"Xing","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.pnpbp.2021.110343_bb0530","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.3892\/etm.2013.930","article-title":"Ketamine exerts antidepressant effects and reduces IL-1beta and IL-6 levels in rat prefrontal cortex and hippocampus","volume":"5","author":"Yang","year":"2013","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.pnpbp.2021.110343_bb0535","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/j.biopsych.2014.06.021","article-title":"Serum interleukin-6 is a predictive biomarker for ketamine\u2019s antidepressant effect in treatment-resistant patients with major depression","volume":"77","author":"Yang","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110343_bb0540","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.pnpbp.2009.03.020","article-title":"Higher plasma interleukin-6 (IL-6) level is associated with SSRI- or SNRI-refractory depression","volume":"33","author":"Yoshimura","year":"2009","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110343_bb0545","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/s41398-020-00933-z","article-title":"Alterations of multiple peripheral inflammatory cytokine levels after repeated ketamine infusions in major depressive disorder","volume":"10","author":"Zhan","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110343_bb0550","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41398-018-0256-x","article-title":"Effects of tumor necrosis factor-alpha polymorphism on the brain structural changes of the patients with major depressive disorder","volume":"8","author":"Zhou","year":"2018","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110343_bb0555","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41398-020-01083-y","article-title":"Novel neuronal surface autoantibodies in plasma of patients with depression and anxiety","volume":"10","author":"Zong","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110343_bb0560","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.brainres.2004.11.014","article-title":"TNF alpha potentiates glutamate neurotoxicity by inhibiting glutamate uptake in organotypic brain slice cultures: neuroprotection by NF kappa B inhibition","volume":"1034","author":"Zou","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.pnpbp.2021.110343_bb0565","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0197267","article-title":"Changes in the serum levels of inflammatory cytokines in antidepressant drug-naive patients with major depression","volume":"13","author":"Zou","year":"2018","journal-title":"PLoS One"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584621001020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584621001020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T19:56:57Z","timestamp":1759521417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584621001020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":113,"alternative-id":["S0278584621001020"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2021.110343","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Translational evidence for the Inflammatory Response System (IRS)\/Compensatory Immune Response System (CIRS) and neuroprogression theory of major depression","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2021.110343","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110343"}}